• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.

作者信息

Gombos Katalin, Földi Mária, Kiss Szabolcs, Herczeg Róbert, Gyenesei Attila, Geiger Lili, Csabai Dávid, Futács Krisztina, Nagy Tamás, Miseta Attila, Somogyi Balázs Antal, Hegyi Péter, Szentesi Andrea

机构信息

Department of Laboratory Medicine, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.

Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.

出版信息

Front Med (Lausanne). 2021 Jan 26;7:625673. doi: 10.3389/fmed.2020.625673. eCollection 2020.

DOI:10.3389/fmed.2020.625673
PMID:33575263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7870862/
Abstract

Effective testing is an essential tool for controlling COVID-19. We aimed to analyse the data from first-wave PCR test results in Hungary's Southern Transdanubian region to improve testing strategies. We performed a retrospective analysis of all suspected COVID-19 cases between 17 March and 8 May 2020, collecting epidemiological, demographic, clinical and outcome data (ICU admission and mortality) with RT-qPCR test results. Descriptive and comparative statistical analyses were conducted. Eighty-six infections were confirmed among 3,657 tested patients. There was no difference between the positive and negative cases in age and sex distribution; however, ICU admission (8.1 vs. 3.1%, = 0.006) and in-hospital mortality (4.7 vs. 1.6%, = 0.062) were more frequent among positive cases. Importantly, none of the initially asymptomatic patients ( = 20) required ICU admission, and all survived. In almost all cases, if the first test was negative, second and third tests were performed with a 48-h delay for careful monitoring of disease development. However, the positive hit rate decreased dramatically with the second and third tests compared to the first (0.3 vs. 2.1%, OR = 0.155 [0.053-0.350]). Higher E-gene copy numbers were associated with a longer period of PCR positivity. In our immunologically naïve suspected COVID-19 population, coronavirus infection increased the need for intensive care and mortality by 3-4 times. In the event of the exponential phase of the pandemic involving a bottleneck in testing capacity, a second or third test should be reconsidered to diagnose more coronavirus infections.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/8a9a275b23c5/fmed-07-625673-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/dedbf64a3ddb/fmed-07-625673-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/e514d171f647/fmed-07-625673-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/44c65bba7e47/fmed-07-625673-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/8a9a275b23c5/fmed-07-625673-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/dedbf64a3ddb/fmed-07-625673-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/e514d171f647/fmed-07-625673-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/44c65bba7e47/fmed-07-625673-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d51c/7870862/8a9a275b23c5/fmed-07-625673-g0004.jpg

相似文献

1
Analysis of COVID-19-Related RT-qPCR Test Results in Hungary: Epidemiology, Diagnostics, and Clinical Outcome.
Front Med (Lausanne). 2021 Jan 26;7:625673. doi: 10.3389/fmed.2020.625673. eCollection 2020.
2
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.在普通人群中进行 SARS-CoV-2 监测的四种不同策略的有效性和成本效益(CoV-Surv 研究):一项关于集群随机、双因素对照试验的研究方案的结构化总结。
Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z.
3
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
4
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
5
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
Pregnancy Outcomes in Women With SARS-CoV-2 Infection During the First and Second Waves of the COVID-19 Pandemic in a Tertiary Care Hospital in Ayodhya, Uttar Pradesh, India: A Comparative Study.印度北方邦阿约提亚一家三级护理医院在新冠疫情第一波和第二波期间感染新冠病毒2型的女性的妊娠结局:一项比较研究
Cureus. 2023 Feb 14;15(2):e34969. doi: 10.7759/cureus.34969. eCollection 2023 Feb.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.在医院环境中评估羟氯喹化学预防 SARS-CoV2 感染在医护人员中的疗效和安全性的对照、双盲、随机试验:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):472. doi: 10.1186/s13063-020-04400-4.
10
Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.新德里一家三级医疗中心SARI病房中新冠病毒患者的临床和流行病学特征
J Assoc Physicians India. 2020 Jul;68(7):19-26.

引用本文的文献

1
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
2
The Value of Early Positive Nucleic Acid Test and Negative Conversion Time of SARS-CoV-2 RNA in the Clinical Outcome of COVID-19 Patients.新型冠状病毒核酸早期阳性检测结果及病毒核糖核酸转阴时间对新型冠状病毒肺炎患者临床结局的影响
Front Med (Lausanne). 2022 Apr 28;9:826900. doi: 10.3389/fmed.2022.826900. eCollection 2022.
3
SARS-CoV-2 in Egypt: epidemiology, clinical characterization and bioinformatics analysis.

本文引用的文献

1
Translating Scientific Knowledge to Government Decision Makers Has Crucial Importance in the Management of the COVID-19 Pandemic.将科学知识转化为政府决策者对于 COVID-19 大流行的管理具有至关重要的意义。
Popul Health Manag. 2021 Feb;24(1):35-45. doi: 10.1089/pop.2020.0159. Epub 2020 Sep 2.
2
Extensive Testing May Reduce COVID-19 Mortality: A Lesson From Northern Italy.广泛检测可能降低新冠死亡率:来自意大利北部的经验教训
Front Med (Lausanne). 2020 Jul 14;7:402. doi: 10.3389/fmed.2020.00402. eCollection 2020.
3
Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis.
埃及的严重急性呼吸综合征冠状病毒2:流行病学、临床特征及生物信息学分析
Heliyon. 2022 Feb;8(2):e08864. doi: 10.1016/j.heliyon.2022.e08864. Epub 2022 Jan 31.
肥胖是 COVID-19 患者发展为危急病情的一个风险因素:系统评价和荟萃分析。
Obes Rev. 2020 Oct;21(10):e13095. doi: 10.1111/obr.13095. Epub 2020 Jul 19.
4
SARS-CoV-2 detection, viral load and infectivity over the course of an infection.在感染过程中对 SARS-CoV-2 的检测、病毒载量和传染性。
J Infect. 2020 Sep;81(3):357-371. doi: 10.1016/j.jinf.2020.06.067. Epub 2020 Jun 29.
5
The negative impact of comorbidities on the disease course of COVID-19.合并症对新型冠状病毒肺炎病程的负面影响。
Intensive Care Med. 2020 Sep;46(9):1784-1786. doi: 10.1007/s00134-020-06161-9. Epub 2020 Jun 29.
6
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital.意大利北部一家大学医院在 COVID-19 大流行的最新阶段鼻咽部病毒载量较低。
Clin Chem Lab Med. 2020 Jun 29;58(9):1573-1577. doi: 10.1515/cclm-2020-0815. Print 2020 Aug 27.
7
Host response-based screening to identify undiagnosed cases of COVID-19 and expand testing capacity.基于宿主反应的筛查,以识别未确诊的新冠病毒病病例并扩大检测能力。
medRxiv. 2020 Jun 5:2020.06.04.20109306. doi: 10.1101/2020.06.04.20109306.
8
Global Comparison of Changes in the Number of Test-Positive Cases and Deaths by Coronavirus Infection (COVID-19) in the World.全球范围内冠状病毒感染(COVID-19)检测呈阳性病例数和死亡人数变化的比较。
J Clin Med. 2020 Jun 18;9(6):1904. doi: 10.3390/jcm9061904.
9
The epidemiologic and clinical features of suspected and confirmed cases of imported 2019 novel coronavirus pneumonia in north Shanghai, China.中国上海北部输入性新型冠状病毒肺炎疑似及确诊病例的流行病学和临床特征
Ann Transl Med. 2020 May;8(10):637. doi: 10.21037/atm-20-2119.
10
Asymptomatic and Pre-Symptomatic COVID-19 in China.中国的无症状和症状前新冠病毒感染情况。
Infect Dis Poverty. 2020 Jun 22;9(1):72. doi: 10.1186/s40249-020-00679-2.